Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03253432 · ClinicalTrials.gov registry record
IN-TANDEM Familial Hypercholesterolemia Pilot Study
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 378
- Enrollment target
NCT03253432: Completed study, sponsored by University of Pennsylvania.
NCT03253432 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 378 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03253432 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 378 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the use of the FH Foundation FIND FH® Algorithm as a clinical decision support tool. FIND FH (Flag/Identify/Network/Engage) is a national initiative that utilizes machine learning and data mining techniques to identify individuals whose profiles are consistent with FH patients. The algorithm will be tested in adults with at least one cardiovascular comorbidity. Study subjects will be asked to provide either a saliva, buccal or venous blood sample for DNA and biomarker analysis
Primary Outcome
Proportion of subjects with causative mutation in higher algorithm score groups
Interventions
- OTHER Genetic testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 378 participants |
| Start Date | 2017-07-20 |
| Est. Completion | 2018-11-07 |
What the finished NCT03253432 record still lists
NCT03253432 is an observational study that tracks outcomes without assigning an intervention. The registered 378 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Genetic testing is the first listed.
NCT03253432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03253432 about?
NCT03253432 is a clinical study titled "IN-TANDEM Familial Hypercholesterolemia Pilot Study". The purpose of this study is to validate the use of the FH Foundation FIND FH® Algorithm as a clinical decision support tool. FIND FH (Flag/Identify/Network/Engage) is a national initiative that utilizes machine learning and data mining techniques to identify individuals whose profiles are consisten...
What is the current status of trial NCT03253432?
This trial is currently completed. The enrollment target is 378 participants. The study started on 2017-07-20. Estimated completion is 2018-11-07.
What interventions are being tested in trial NCT03253432?
The interventions under investigation include: Genetic testing (OTHER).
Who is sponsoring clinical trial NCT03253432?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04254185 · 378 participants · NA
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow
- NCT06616584 · 378 participants · Phase 2
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- NCT07024784 · 377 participants · Phase 2
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI